IL22 and breast carcinoma: To investigate whether Dock1 involves in IL-22 triggered breast cancer invasion by EMT, EMT markers (E-cadherin and Vimentin) were assessed using western blot and immunofluorescence with or without 10 ng/mL IL-22 stimulation for 48 hours.